CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for NERVGEN PHARMA CORP. · Medical, pharma

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $50,000.00 income · posted Jan 7, 2026

Lobbying activity 3

Veterans

Legislation related to spinal cord injury research and treatment.

Defense

Legislation related to central nervous system research and therapeutics

Health Issues

Legislation related to spinal cord injury research, therapeutics and approvals

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.